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ProphylaxisA B S T R A C T
New scientific approaches are necessary: The current strategies for controlling tuberculosis
(TB) are not sufficient. Improved prophylactic and diagnostic tools are imperative, being
crucial for decreasing TB incidence and mortality and for preventing outbreaks. Further-
more, new and better drugs are badly needed, particularly considering the increase in cases
with multidrug-resistant strains. The current TB vaccine—the Bacillus Calmette–Gue´rin
vaccine—has a preventive impact on disseminated TB in children, but little effect on the
most common form of TB, that is, lung TB in adults and young adults. For many years
extensive scientific efforts have been made in order to develop new vaccines against TB
that are better and more effective than Bacillus Calmette–Gue´rin. No such vaccine exists,
however, to date. During the last few years it has become increasingly clear that TB patients
can be infected with more than one strain and that a previous TB infection increases rather
than decreases the risk for getting a new one.Mycobacterium tuberculosis organisms are thus
not capable of inducing protective immunity to such an extent that a new TB infection is
prevented. This phenomenon highlights the problems of developing effective vaccines
against TB. A new TB vaccine based on general immunological protection models would
in all probability only have a limited capacity to hamper TB incidence and mortality. The
question whether or not it is feasible to make a vaccine of sufficient efficacy must therefore
be discussed. Prophylaxis is practically always far better than therapy and we all wish we
had an effective TB vaccine. However, considering the problems with vaccines, scientific
efforts could well focus on developing new therapies rather than new vaccines. New scien-
tific approaches are highly necessary and we need ideas and visions. Some examples of
recent projects will hereby be presented. One study concerns the mycobacterial cell envel-
ope and its unique macromolecules as targets for new drugs. Another study concerns new
ways of administrating the drugs which could enhance the effects of new as well as of
already available drugs. In addition, what can be learnt from cancer therapy—is supporting
the patient’s own defense by immune modularly methods a possible approach? We also
need to look back since ample knowledge on TB has been assembled during many years.
Unfortunately some of this valuable knowledge is about to be forgotten, particularly, the
experience from the time when TB was an incurable disease.l address:
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